Understanding what we know, and what we don't know, about long-term use helps you make informed decisions
Excessive tirzepatide exposure can cause severe nausea, vomiting, diarrhea, abdominal pain, acute pancreatitis, hypoglycemia, and rapid dehydration
CVS steps up to help GLP-1 customers New approach includes lower-cost access, pharmacist support and products to help manage common side effects June 23, 2026 As demand for GLP-1 medications continues to increase across the U.S., CVS Health on Monday announced a comprehensive approach to GLP-1 support spanning its more than 9,000 CVS Pharmacy locations and MinuteClinic, available virtually in nearly all states
Our goal is to ensure that every patient has access to a weight loss program that aligns with their goals and financial circumstances
Confirmation requires capillary blood glucose measurement during symptomatic episodes, ideally demonstrating glucose levels below 3.0 mmol/L with symptom resolution following carbohydrate intake (Whipple's triad)
A growing body of research points to a range of other tirzepatide benefits, such as: Accelerated fat loss Reduced systemic inflammation Enhanced hepatoprotection Read on as we break down the latest evidence on the benefits of this novel weight loss agent